🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Current Issue: Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites dlvr.it/RYH50X

Muscle symptoms are common, also in statin users. We should focus on other causes then the drug.

Atorvastatin does not affect the intensity of muscle symptoms in patients with self-perceived SAMS: results from a randomized trial. bit.ly/2ZxgZQ5 #cardiotwitter #EHJPharmacotherapy Stefan Agewall

Ahead-of-Print in Therapeutic Drug Measuring Intracellular Concentrations of Calcineurin... : Therapeutic Drug Monitoring journals.lww.com/drug-monitorin…

Emerging evidence suggests that optimal lipid lowering therapy produces the greatest absolute reduction in apoB. Because 90% of circulating apoB particles are LDL, therapy that reduces LDL-C (eg #statins) are optimal first therapy for most people ja.ma/2BkbkUi

Encephalopathy and coma developed in a 13-year-old boy shortly after he received a single dose of ivermectin to prevent scabies infection. ABCB1 sequencing identified the child as a compound heterozygote for two nonsense mutations.

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Clopidogrel on Ischemic Outcomes After PCI ja.ma/3buRJOV via JAMA part of JAMA Network

Humans with heart failure are characterized by a unique transcriptome signature in skeletal muscle @ScienceLeeds ow.ly/GUBj50BrxAe #AHAJournals

Excellent presentation by our PhD candidate Jonas Pivoriunas at #ESCPrev2024 ✅ statin adherence measured with our novel blood test strongly aligns with long-term adherence assessed by pharmacy registry. The blood test emerges as a promising tool for enhancing lipid management

Excellent presentation by our PhD candidate Trine Lauritzen at #ESCPrev2024 ✅ The first study evaluating mevalonate in blood and muscle as potential biomarker of statin intolerance Nils Tore Vethe Vestre Viken